Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
28.17
-0.71 (-2.46%)
At close: Apr 9, 2026, 4:00 PM EDT
28.65
+0.48 (1.70%)
After-hours: Apr 9, 2026, 4:29 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $13.93 billion as of April 9, 2026. Its market cap has increased by 2,510.88% in one year.
Market Cap
13.93B
Enterprise Value
14.02B
1-Year Change
2,510.88%
Ranking
Category
Stock Price
$28.17
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $13.93B, an increase of 11,498.46%. That is a compound annual growth rate of 173.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 14.28B | 37.52% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | 120.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zoetis | 49.92B |
| Haleon | 44.03B |
| Teva Pharmaceutical Industries | 34.72B |
| United Therapeutics | 24.53B |
| Viatris | 15.44B |
| Neurocrine Biosciences | 13.30B |
| Elanco Animal Health | 11.35B |
| Dr. Reddy's Laboratories | 10.71B |